Skip to main content

Table 1 Clinical features in 98 DLBCL Brazilian patients

From: Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients

  n = 98
Male, n (%) 49 (50.0)
Age, median (IQR) 54.5 (46.2–66.7)
BM+, n (%) 13 (13.3)
CNS+, n (%) 2 (2.0)
Extranodal sites ≥2, n (%) a 7 (7.1)
ECOG > 2, n (%) b 50 (50.0)
Bulky disease, n (%) b 44 (44.9)
B symptoms, n (%) a 66 (67.3)
Stage, n (%) c
 I 10 (10.2)
 II 30 (30.6)
 III 13 (13.2)
 IV 41 (41.8)
IPI, n (%) d
 Low risk 24 (24.5)
 Low-intermediate 20 (20.4)
 Intermediate-high 22 (22.4)
 High risk 27 (27.5)
  1. Missing data:
  2. a n = 6 (6,1%)
  3. b n = 8 (8,1%)
  4. c n = 4 (4,1%)
  5. d n = 5 (5,1%)